Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
6 Athira Pharma LIFT-AD topline results (press release)September 3, 2024 announcement that fosgonimeton (a distinct HGF/c-Met modulator) did not meet the primary or key secondary endpoints in the Phase 2/3 LIFT-AD Alzheimers trial
Clinical Benefits Four peptides working together create therapeutic effects greater than individual components, providing comprehensive regenerative support across multiple systems
Laboratory studies have continued to investigate its role in sleep-wake cycle regulation and its interactions with endogenous sleep-promoting systems
They possess remarkable talent when it comes to injectables and skincare treatments, and I have always been thrilled with the results I've achieved
